| David Wesley Boone, DO | |
|
856 1st St, Macon, GA 31201-6875 | |
| (478) 741-1740 | |
| (478) 745-2887 |
| Full Name | David Wesley Boone |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 25 Years |
| Location | 856 1st St, Macon, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093798753 | NPI | - | NPPES |
| 000000495130 | Other | ANTHEM | |
| 200838980 | Medicaid | IN |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vision Eye Group | 0345581229 | 7 |
News Archive
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, announces today that the Data and Safety Monitoring Board, an independent committee of experts which monitors safety data every six months during the study, met as scheduled on January 22nd. It recommended the RHEIA-VAC study proceed without any modifications.
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Thermage, Inc. has announced that it has filed a patent infringement lawsuit against Alma Lasers, Ltd. and Alma Lasers, Inc. in Delaware Federal District Court.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
› Verified 8 days ago
| Entity Name | Vision Eye Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013471721 PECOS PAC ID: 0345581229 Enrollment ID: O20190402000861 |
News Archive
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, announces today that the Data and Safety Monitoring Board, an independent committee of experts which monitors safety data every six months during the study, met as scheduled on January 22nd. It recommended the RHEIA-VAC study proceed without any modifications.
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Thermage, Inc. has announced that it has filed a patent infringement lawsuit against Alma Lasers, Ltd. and Alma Lasers, Inc. in Delaware Federal District Court.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
› Verified 8 days ago
| Entity Name | Vision Eye Surgery Center |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1437714425 PECOS PAC ID: 5193059574 Enrollment ID: O20190619002516 |
News Archive
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, announces today that the Data and Safety Monitoring Board, an independent committee of experts which monitors safety data every six months during the study, met as scheduled on January 22nd. It recommended the RHEIA-VAC study proceed without any modifications.
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Thermage, Inc. has announced that it has filed a patent infringement lawsuit against Alma Lasers, Ltd. and Alma Lasers, Inc. in Delaware Federal District Court.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Wesley Boone, DO 8043 Rivoli Rd Unit 428, Bolingbroke, GA 31004-3019 Ph: (478) 744-1710 | David Wesley Boone, DO 856 1st St, Macon, GA 31201-6875 Ph: (478) 741-1740 |
News Archive
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, announces today that the Data and Safety Monitoring Board, an independent committee of experts which monitors safety data every six months during the study, met as scheduled on January 22nd. It recommended the RHEIA-VAC study proceed without any modifications.
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Thermage, Inc. has announced that it has filed a patent infringement lawsuit against Alma Lasers, Ltd. and Alma Lasers, Inc. in Delaware Federal District Court.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
› Verified 8 days ago
Dr. Herbert Sam Greenwald Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5067 Wellington Dr, Macon, GA 31210 Phone: 478-474-7430 Fax: 478-474-6247 | |
Dr. Felicity Araba Quansah, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1870 Hardeman Ave, Macon, GA 31201 Phone: 478-743-2000 Fax: 478-743-0096 | |
Dr. Richard Eisner, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 125 Plantation Centre Dr, Suite 250, Macon, GA 31210 Phone: 478-405-2020 | |
Joe L Mclendon, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 626 1st St, Macon, GA 31201 Phone: 478-743-4666 Fax: 478-743-4740 | |
Steven Dean Allee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 160 Water Tower Ct, Macon, GA 31210 Phone: 478-757-8806 Fax: 478-757-8667 | |
Dr. Spencer F Maddox Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1429 Oglethorpe St, Macon, GA 31201 Phone: 478-743-7061 Fax: 478-743-6296 |